US Patent Issued to DOUGLAS PHARMACEUTICALS on July 14 for "Lopinavir and ritonavir for the treatment of cervix disorders" (British Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,439, issued on July 14, was assigned to DOUGLAS PHARMACEUTICALS Ltd. (Lincoln, New Zealand).

"Lopinavir and ritonavir for the treatment of cervix disorders" was invented by Ian Hampson (Manchester, Great Britain) and Lynne Hampson (Manchester, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention concerns pharmaceutical compositions formulated for topical application that are useful in the treatment of HPV-related pathologies and in particular the treatment of premalignant and malignant conditions of the cervix. The compositions comprise a therapeutically effective amount of lopinavir and ritonavir in a pharmaceutically ...